Teva shares plummet amid CEO departure and bribery reports
Teva (TEVA) Agrees to $225 Million Texas Opioid Settlement, AG Says - Bloomberg
Teva stock drops after conspiracy allegations on hiking drug prices
Teva Pharmaceutical to Replace CEO Kare Schultz - WSJ
Teva CEO Calls 'Trough' Revenues Consequence of Patent Expirations - YouTube
Teva CEO Says Drugmaker Will Fight U.S. Price-Fixing Charges (2)
Teva Pharmaceuticals found to be responsible for its role in the opioid epidemic in New York State | CNN
Teva flags supply constraints to ADHD drug Adderall as demand rises (NYSE: TEVA) | Seeking Alpha
Teva CEO Rejects Netanyahu Plea to Salvage Jerusalem Plant - Bloomberg
Teva Prepared to Fight Charges in Generics Probe If Talks Fail - Bloomberg
Teva Is Facing Adderall Supply Disruptions as Demand for ADHD Drug Soars - Bloomberg
Israeli pharmaceutical company donating millions of doses of potential coronavirus drug to the U.S.
Teva to Sell Record $5 Billion of Sustainability-Linked Bonds - BNN Bloomberg
Teva Analysts Say Migraine Drug Approval Gives Needed Relief - Bloomberg
Teva Pharma's Short Sellers Double Down as Legal Woes Drag On - Bloomberg
Teva Is at Center of Drug Price-Fixing Case Filed by States - Bloomberg
Teva CEO Vigodman Steps Down After Poor Outlook for 2017 | Fortune
Teva's Credit Rating Cut to Junk by Fitch - Bloomberg
Teva makes $40.1 billion takeover bid for Mylan | Mint
Teva Pharmaceuticals to Cut 25% of Jobs in Huge Reshaping - The New York Times
Future Teva CEO Seeks to 'Formulate Clear Strategy' - YouTube
A bottle of Teva Pharmaceutical Industries Ltd. Clonazepam medication... News Photo - Getty Images
Teva Is Facing Adderall Supply Disruptions as Demand for ADHD Drug Soars - BNN Bloomberg
Teva Negotiating Sale of Remaining Women's Health Assets, Report Says | Ctech
